Shire PLC (NASDAQ:SHPG) declared a semiannual dividend on Friday, February 16th, Wall Street Journal reports. Investors of record on Friday, March 9th will be paid a dividend of 0.8937 per share by the biopharmaceutical company on Tuesday, April 24th. This represents a yield of 1.33%. The ex-dividend date of this dividend is Thursday, March 8th. This is a boost from Shire’s previous semiannual dividend of $0.15.
Shares of Shire (NASDAQ SHPG) traded up $1.34 during trading hours on Wednesday, reaching $132.56. 522,875 shares of the company traded hands, compared to its average volume of 1,367,498. The firm has a market cap of $39,730.00, a P/E ratio of 21.84, a P/E/G ratio of 0.77 and a beta of 1.43. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.97 and a quick ratio of 0.55. Shire has a twelve month low of $123.73 and a twelve month high of $192.15.
Shire (NASDAQ:SHPG) last released its quarterly earnings results on Wednesday, February 14th. The biopharmaceutical company reported $3.98 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.86 by $0.12. The firm had revenue of $4.14 billion for the quarter. Shire had a net margin of 28.17% and a return on equity of 14.19%. The firm’s revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the company earned $3.37 earnings per share. equities research analysts anticipate that Shire will post 15.23 earnings per share for the current year.
Several research analysts have weighed in on SHPG shares. Cowen set a $225.00 price target on shares of Shire and gave the company a “buy” rating in a report on Friday, January 5th. JPMorgan Chase & Co. cut shares of Shire from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $200.00 to $150.00 in a report on Monday, February 19th. Liberum Capital raised shares of Shire from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Cantor Fitzgerald set a $222.00 target price on shares of Shire and gave the stock a “buy” rating in a report on Tuesday, December 5th. Finally, Zacks Investment Research cut shares of Shire from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $204.00.
ILLEGAL ACTIVITY NOTICE: “Shire PLC (NASDAQ:SHPG) Announces Semiannual Dividend of $0.89” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://ledgergazette.com/2018/03/14/shire-plc-shpg-to-issue-semiannual-dividend-of-0-89-on-april-24th.html.
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.